Skip to main content
Premium Trial:

Request an Annual Quote

Genome Institute of Singapore, OBD Collaborate on Stem Cell Epigenetic Signatures

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore today announced an agreement with Oxford Biodynamics to identify epigenetic signatures in stem cells.

The collaboration leverages OBD's EpiSwitch biomarker discovery platform, which allows researchers to discover and monitor highly specific epigenetic biomarkers called chromosome conformation signatures. These biomarkers define and control important elements of epigenetic and gene regulation.

UK-based OBD said on its website that EpiSwitch uses a machine-learning algorithm to identify DNA patterns "that are likely to form higher order structures. The algorithm tracks implicit information embedded in the genome that probably signifies the borders of transcription units."

GIS added that EpiSwitch can differentiate or confirm the epigenetic footprint of induced pluripotent stem cells (IPSC), embryonic stem cells, or progenitor cells from representative cell lines. In the first application of the platform under today's deal, EpiSwitch biomarkers "will provide a quick and efficient tool to monitor the quality and safety of IPSCs," said GIS, an institute of the Agency for Science, Technology and Research.

Financial and other terms of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.